PMDA drug package insert
シンプトップ
PMDA OTC drug · アルフレッサ ファーマ株式会社 · package insert Apr 3, 2023
Key facts
| Brand names | シンプトップ |
|---|---|
| Companies | 製造販売元／アルフレッサ ファーマ株式会社 |
| Product type | OTC drug |
| OTC risk class | 第３類医薬品 |
| OTC dosage form | カプセル |
| OTC effect category | 動脈硬化用薬（リノール酸，レシチン主薬製剤等） |
| Package insert date | Apr 3, 2023 |
| PMDA document key | 530258_K1106000008 |
| PMDA company code | 530258 |
At a glance
- 1–9 Package insert revisions
- None Related PMDA documents
- None Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: